Early scan hopes to predict cervical cancer outcomes
NCT ID NCT01641484
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether MRI and PET scans taken two weeks into radiotherapy can predict if cervical cancer will be controlled. Researchers measured tumor size and activity in 9 patients with stage I to IIIB cervical cancer. The goal was to find early signs of treatment failure, but the study was stopped early, so results are limited.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors identify early which patients need more aggressive treatment for cervical cancer.
- What could go wrong
- The study was terminated early with only 9 participants, so results are very limited and may not apply broadly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVIX CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Oscar Lambret Center
Lille, 59020, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a breathing exercise and music tame cancer treatment fatigue?
- Can a Finger-Prick replace the lab draw? a device puts accuracy to the test
- Exercise may boost immunotherapy in kidney cancer
- Which radiotherapy technique offers best value for pelvic cancers?
- Scientists test novel way to detect pancreatic cancer from biopsy fluid
- Can exercise help cancer patients? new study aims to find out